2nd Quarter - Report

EMPIRE CONSULTING GROUP for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues pertaining to cell and gene therapies; H. Res 1176 (World Sickle Cell Awareness Day); and issues related to Vertex's scientific advances/innovations and therapies.

LobbyistCovered position, as disclosed
MIKE MCKAY —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; White House Office

Bills named: H.Res. 1176 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.